Radiofrequency ablation of liver metastases from cancer of unknown primary site

Diagnostic and Interventional Radiology

Volumn 15, Issue 4, 2009, Pages 297-302

  Mylona, Sophia ^a   Stroumpouli, Evangelia ^a   Pomoni, Maria ^c   Galani, Panagiota ^a   Ntai, Sparti ^a   Thanos, Loukas ^b  

^a RED CROSS HOSPITAL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c Evgenidion Hospital   (Greece)

Author keywords

Liver; Neoplasms, unknown primary; Radiofrequency ablation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CANCER; LIVER METASTASIS; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIOFREQUENCY ABLATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CAUSE OF DEATH; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; RADIO WAVES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74549220782     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.1714-08.1     Document Type: Article

References (24)

1. Pavlides N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39:1990-2005.
2. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004; 100:1776-1785.
3. Ayoub JP, Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Unknown primary tumors metastatic to liver. J Clin Oncol 1998; 16:2105-2112.
4. Hogan BA, Thornton FJ, Brannigan M, et al. Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations. Clin Radiol 2002; 57:1073-1079.
5. Van de Wouw AJ, Jansen RL, Griffioen AW, Hillen HF. Clinical and immunohistochemical analysis of patients with unknown primary tumor. A search for prognostic factors in UPT. Anticancer Res 2004; 24:297-301.
6. Penna C, Nordliger B. Colorectal metastasis (liver and lung). Surg Clin North Am 2002; 82:1075-1090.
7. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable liver metastasis. J Am Coll Surg 2002; 195:378-386.
8. Song SY, Kim WS, Lee HR, et al. Adenocarcinoma of unknown primary site. Korean J Intern Med 2002; 17:234-239.
9. Shaw PH, Adams R, Jordan C, Crosby TD. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network. Clin Oncol (R Coll Radiol) 2007; 19:87-95.
10. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2005; 16:765-778.
11. Bhattacharya R, Rao S, Kowdley K. Liver involvement in patients with solid tumors of nonhepatic origin. Clin Liver Dis 2002; 6:1033-1043.
12. Choti MA, Bulkley GB. Management of metastatic disease. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. Philadelphia: Lippincott-Raven, 1999; 1319-1333.
13. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170:1015-1022.
14. Ambrosini V, Nanni C, Rubello D, et al. 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin. Radiol Med 2006; 111:1146-1155.
15. Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumors (UPT). Eur J Cancer 1999; 35:1076-1082.
16. Bohuslavizki KH, Klutmann S, Kroger S, et al. FDG PET detection of unknown primary tumors. J Nucl Med 2000; 41:816-822.
17. Blaszyk H, Hartmann A, Bjornsson J. Cancer of unknown primary: clinicopathologic correlations. APMIS 2003; 111:1089-1094.
18. Briasoulis E, Pavlidis N. Cancer of unknown primary origin. Oncologist 1997; 2:142-152.
19. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001; 13:149-158.
20. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radiofrequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998; 209:371-379.
21. Solbiati L, Goldberg SN, Ierace T, Livraghi T, Sironi S, Gazelle GS. Hepatic metastases: percutaneous radiofrequency ablation with cooled tip electrodes. Radiology 1997; 205:367-374.
22. Hawksworth J, Geisinger K, Zagoria R, et al. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg 2004; 70:512-517.
23. Briasoulis E, Kalofonos H, Bafaloukos D, et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol 2000; 18:3101-3107.
24. Greco FA, Burris HA, Litchy S, et al. Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network Study. J Clin Oncol 2002; 20:1651-1656.